Emergen Research latest document, titled ‘Global Reproductive Genetics Market - Forecast to 2027,’ is one of the most sought-after market reports involving an in-depth analysis of the global Reproductive Genetics market. The report’s authors have offered necessary details on the latest Reproductive Genetics market trends and the crucial parameters impacting both short-term and long-term market growth.

Advancements in genomic technologies and implementation of these technologies in clinical medicine has expanded their usage in diagnosis of genetic disorders, carrier screening, and identification of cause of infertility. Some tests are quite expensive, which deters couples from going ahead with the tests, but as there is a decline in cost of sequencing and surge in mixed-ethnicity population, an increasing number of  couples/individuals are expected to opt for the procedure and this is expected to support market growth going ahead.Chromosomal abnormalities are responsible for 50% of miscarriages in first trimester. Reproductive genetics identifies embryos without these abnormalities so that they can be used for IVF, thus increasing the likelihood of healthy pregnancy and baby regardless of patient health. It also helps in achieving higher pregnancy rates per transfer, which reduces the need for IVF and results in low cost, time, and stress.

Get a sample of the report : https://www.emergenresearch.com/request-sample/695

Some Key Highlights from the Report

In May 2021, Juno Diagnostics, Which is a company focusing on enhancing access to genetic health information, announced that closing of Series A financing round for USD 25 million led by Perceptive Xontogeny Venture (PXV) Fund. The fund will support product development, clinical validation studies, and commercial launch of JunoDx’s product offerings for non-invasive prenatal testing.

Prenatal screening covers a variety of tests doctors recommend for a pregnant patient. Some prenatal screening tests determines the chances a baby may or may not have chromosomal disorders, such as Down Syndrome. Though recommended by doctors, it is non-invasive and optional, and poses no risk to pregnancy as it involves ultrasound and blood work.

Next Generation Sequencing (NGS) is a widely accepted genetic testing technology in the prenatal testing arena. NGS is able to detect embryos with unbalanced chromosomal translocations that were not identified earlier. NGS offers better coverage of the chromosomes, higher resolution, and is faster and more affordable.

Single gene disorders are among the most understood genetic disorders due to their inheritance patterns and relatively simple genetic causes. Some of the most common single gene disorders are sickle cell anaemia, hemochromatosis, cystic fibrosis, and Tay-Sachs. Reproductive genetic tests are done to detect the possibility of single gene disorders in babies.

Asia Pacific market revenue is expected to register a rapid CAGR during the forecast period due to increasing demand of genetic testing from India and China. In addition, increased utilization of IVF procedures and advancements in the healthcare sector are major factors driving growth of the market in the region.

Key players in the market include Illumina, Inc., Agilent Technologies, Inc., PerkinElmer, Inc., Quest Diagnostics, Thermo Fisher Scientific Inc., Fulgent Genetics, Inc., Centogene AG, Myriad Genetics, Inc., Qiagen N.V., and OPKO Health, Inc.

Request a discount on the report : https://www.emergenresearch.com/request-discount/695

Highlights of the TOC: 

Report Overview 
1.1 Research Scope
1.2 Key Reproductive Genetics market segments
1.3 Major players
1.4 Market analysis by product
1.5 Market analysis by application
1.6 Report timeline

Global Growth Trends 
2.1 Global Reproductive Genetics market size
2.2 Latest Reproductive Genetics market trends
2.3 Key growth trends

Competitive Landscape 
3.1 Global Reproductive Genetics market key players
3.2 Global Reproductive Genetics size by manufacturers
3.3 Products of major players
3.4 Entry barriers in the Reproductive Genetics market
3.5 Mergers, acquisitions, joint ventures, and strategic alliances

Key geographical areas:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East Africa

The report considers the following timeline for market estimation:

• Historical Years: 2017-2018
• Base Year: 2019
• Estimated Year: 2027
• Forecast Years: 2020-2027

Valuable Market Insights:

• The report highlights the latest trends observed in the consumption pattern of each regional segment.
• Extensive market segmentation included in the report helps better understand the revenue and estimated growth of the individual regions.
• The report throws light on the historical and current market scenarios and provides a concise year-on-year growth rate of the global Reproductive Genetics market.
• The report further entails the current market trends, technological advancements, revenue growth, and other aspects affecting market growth.

Read More : https://www.emergenresearch.com/industry-report/reproductive-genetics-market

Related reports:

About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research   and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkdIn | Twitter | Blogs